Rare diseases
Investigational molecules
Locations
Back to Italy1 clinical trial in Ostia Lido (Roma), Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on atherosclerotic cardiovascular disease in patients with end-stage kidney disease (ESKD). The research evaluates novel therapeutic approaches using CSL300 to reduce inflammation markers in dialysis patients.
This research aims to improve cardiovascular outcomes in patients undergoing maintenance dialysis through targeted therapeutic interventions.
Innovative research examining treatment strategies for IgA nephropathy through targeted therapy based on kidney biopsy findings. The study compares different therapeutic approaches including corticosteroids and SGLT2 inhibitors.
These trials aim to optimize treatment protocols while minimizing potential side effects in patients with various stages of renal lesions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
